questionsmedicales.fr
Maladies de l'appareil digestif
Maladies du foie
Insuffisance hépatique
Défaillance hépatique
Défaillance hépatique : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Défaillance hépatique : Questions médicales les plus fréquentes",
"headline": "Défaillance hépatique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Défaillance hépatique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-04",
"dateModified": "2025-03-31",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Défaillance hépatique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Insuffisance hépatique",
"url": "https://questionsmedicales.fr/mesh/D048550",
"about": {
"@type": "MedicalCondition",
"name": "Insuffisance hépatique",
"code": {
"@type": "MedicalCode",
"code": "D048550",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.308"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Maladie du foie en phase terminale",
"alternateName": "End Stage Liver Disease",
"url": "https://questionsmedicales.fr/mesh/D058625",
"about": {
"@type": "MedicalCondition",
"name": "Maladie du foie en phase terminale",
"code": {
"@type": "MedicalCode",
"code": "D058625",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.308.500.177"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Défaillance hépatique aigüe",
"alternateName": "Liver Failure, Acute",
"url": "https://questionsmedicales.fr/mesh/D017114",
"about": {
"@type": "MedicalCondition",
"name": "Défaillance hépatique aigüe",
"code": {
"@type": "MedicalCode",
"code": "D017114",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.308.500.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Insuffisance hépatique aigüe sur chronique",
"alternateName": "Acute-On-Chronic Liver Failure",
"url": "https://questionsmedicales.fr/mesh/D065290",
"about": {
"@type": "MedicalCondition",
"name": "Insuffisance hépatique aigüe sur chronique",
"code": {
"@type": "MedicalCode",
"code": "D065290",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.308.500.750.249"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Nécrose hépatique massive",
"alternateName": "Massive Hepatic Necrosis",
"url": "https://questionsmedicales.fr/mesh/D047508",
"about": {
"@type": "MedicalCondition",
"name": "Nécrose hépatique massive",
"code": {
"@type": "MedicalCode",
"code": "D047508",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C06.552.308.500.750.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Défaillance hépatique",
"alternateName": "Liver Failure",
"code": {
"@type": "MedicalCode",
"code": "D017093",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "William Bernal",
"url": "https://questionsmedicales.fr/author/William%20Bernal",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Anand V Kulkarni",
"url": "https://questionsmedicales.fr/author/Anand%20V%20Kulkarni",
"affiliation": {
"@type": "Organization",
"name": "Department of Hepatology, Asian Institute of Gastroenterology, Hyderabad, India."
}
},
{
"@type": "Person",
"name": "William M Lee",
"url": "https://questionsmedicales.fr/author/William%20M%20Lee",
"affiliation": {
"@type": "Organization",
"name": "Digestive and Liver Diseases Division, University of Texas Southwestern Medical Center at Dallas, Dallas, TX, USA. Electronic address: william.lee@utsouthwestern.edu."
}
},
{
"@type": "Person",
"name": "Constantine J Karvellas",
"url": "https://questionsmedicales.fr/author/Constantine%20J%20Karvellas",
"affiliation": {
"@type": "Organization",
"name": "Division of Gastroenterology (Liver Unit), Division of Critical Care Medicine, University of Alberta, Edmonton, Alberta, Canada."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Resolution of Liver Function Tests After Laparoscopic Common Bile Duct Exploration Versus Endoscopic Retrograde Cholangiopancreatography.",
"datePublished": "2023-03-03",
"url": "https://questionsmedicales.fr/article/36866709",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/00031348231161688"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of liver function test- and inflammation-based prognostic scores for coronavirus disease 2019: a single center study.",
"datePublished": "2022-09-10",
"url": "https://questionsmedicales.fr/article/36170686",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/MEG.0000000000002446"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluation of liver function tests to identify hepatotoxicity among acute lymphoblastic leukemia patients who are receiving chemotherapy induction.",
"datePublished": "2022-08-02",
"url": "https://questionsmedicales.fr/article/35918381",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-17618-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Clinical predictors of recovery of COVID-19 associated-abnormal liver function test 2 months after hospital discharge.",
"datePublished": "2022-10-26",
"url": "https://questionsmedicales.fr/article/36289394",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-22741-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Nomogram Based on Liver Function Test Indicators for Survival Prediction in Nasopharyngeal Carcinoma Patients Receiving PD-1 Inhibitor Therapy.",
"datePublished": "2023-07-26",
"url": "https://questionsmedicales.fr/article/37623002",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/curroncol30080521"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de l'appareil digestif",
"item": "https://questionsmedicales.fr/mesh/D004066"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies du foie",
"item": "https://questionsmedicales.fr/mesh/D008107"
},
{
"@type": "ListItem",
"position": 4,
"name": "Insuffisance hépatique",
"item": "https://questionsmedicales.fr/mesh/D048550"
},
{
"@type": "ListItem",
"position": 5,
"name": "Défaillance hépatique",
"item": "https://questionsmedicales.fr/mesh/D017093"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Défaillance hépatique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Défaillance hépatique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-07",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Défaillance hépatique",
"description": "Comment diagnostiquer une défaillance hépatique ?\nQuels tests sont utilisés pour évaluer le foie ?\nQuels signes cliniques indiquent une défaillance hépatique ?\nL'échographie est-elle utile pour le diagnostic ?\nQuand faut-il envisager une biopsie hépatique ?",
"url": "https://questionsmedicales.fr/mesh/D017093?mesh_terms=Liver+Function+Tests&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Défaillance hépatique",
"description": "Quels sont les symptômes courants de la défaillance hépatique ?\nLa confusion mentale est-elle un symptôme ?\nComment l'ascite se manifeste-t-elle ?\nLes saignements sont-ils fréquents ?\nLes démangeaisons sont-elles liées à la défaillance hépatique ?",
"url": "https://questionsmedicales.fr/mesh/D017093?mesh_terms=Liver+Function+Tests&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Défaillance hépatique",
"description": "Comment prévenir la défaillance hépatique ?\nL'alimentation joue-t-elle un rôle ?\nLes vaccinations sont-elles importantes ?\nComment éviter les toxines ?\nLe contrôle du poids est-il crucial ?",
"url": "https://questionsmedicales.fr/mesh/D017093?mesh_terms=Liver+Function+Tests&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Défaillance hépatique",
"description": "Quels traitements sont disponibles pour la défaillance hépatique ?\nLes médicaments peuvent-ils aider ?\nQuand envisager une transplantation hépatique ?\nY a-t-il des traitements pour l'ascite ?\nComment gérer la confusion mentale ?",
"url": "https://questionsmedicales.fr/mesh/D017093?mesh_terms=Liver+Function+Tests&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Défaillance hépatique",
"description": "Quelles sont les complications de la défaillance hépatique ?\nL'encéphalopathie hépatique est-elle grave ?\nComment l'hémorragie se produit-elle ?\nLes infections sont-elles fréquentes ?\nQu'est-ce que le syndrome hépatopulmonaire ?",
"url": "https://questionsmedicales.fr/mesh/D017093?mesh_terms=Liver+Function+Tests&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Défaillance hépatique",
"description": "Quels sont les principaux facteurs de risque ?\nL'hépatite C augmente-t-elle le risque ?\nLe diabète est-il un facteur de risque ?\nL'obésité influence-t-elle la santé du foie ?\nLes médicaments peuvent-ils être un risque ?",
"url": "https://questionsmedicales.fr/mesh/D017093?mesh_terms=Liver+Function+Tests&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une défaillance hépatique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sanguins, des examens d'imagerie et l'évaluation des symptômes."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer le foie ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent les transaminases, la bilirubine et l'albumine dans le sang."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent une défaillance hépatique ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent l'ictère, l'ascite, la confusion et la fatigue extrême."
}
},
{
"@type": "Question",
"name": "L'échographie est-elle utile pour le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'échographie aide à visualiser les anomalies du foie et à évaluer sa taille."
}
},
{
"@type": "Question",
"name": "Quand faut-il envisager une biopsie hépatique ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une biopsie est envisagée si les tests ne déterminent pas la cause de la défaillance."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de la défaillance hépatique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent la jaunisse, la fatigue, des démangeaisons et des nausées."
}
},
{
"@type": "Question",
"name": "La confusion mentale est-elle un symptôme ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la confusion peut survenir en raison de l'accumulation de toxines dans le sang."
}
},
{
"@type": "Question",
"name": "Comment l'ascite se manifeste-t-elle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'ascite se manifeste par un gonflement abdominal dû à l'accumulation de liquide."
}
},
{
"@type": "Question",
"name": "Les saignements sont-ils fréquents ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des saignements peuvent survenir en raison de la coagulation altérée."
}
},
{
"@type": "Question",
"name": "Les démangeaisons sont-elles liées à la défaillance hépatique ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les démangeaisons peuvent être causées par l'accumulation de sels biliaires dans le sang."
}
},
{
"@type": "Question",
"name": "Comment prévenir la défaillance hépatique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut un mode de vie sain, l'évitement de l'alcool et la vaccination contre l'hépatite."
}
},
{
"@type": "Question",
"name": "L'alimentation joue-t-elle un rôle ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée et riche en nutriments peut soutenir la santé du foie."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles importantes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, se faire vacciner contre l'hépatite A et B peut prévenir des infections hépatiques."
}
},
{
"@type": "Question",
"name": "Comment éviter les toxines ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez l'exposition aux produits chimiques nocifs et aux médicaments non prescrits."
}
},
{
"@type": "Question",
"name": "Le contrôle du poids est-il crucial ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, maintenir un poids santé réduit le risque de maladies hépatiques et de défaillance."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la défaillance hépatique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la gestion des symptômes, les médicaments et, dans certains cas, la transplantation hépatique."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent traiter les causes sous-jacentes et soulager les symptômes."
}
},
{
"@type": "Question",
"name": "Quand envisager une transplantation hépatique ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La transplantation est envisagée lorsque le foie est gravement endommagé et ne peut pas récupérer."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements pour l'ascite ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des diurétiques et des procédures de drainage peuvent être utilisés pour traiter l'ascite."
}
},
{
"@type": "Question",
"name": "Comment gérer la confusion mentale ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut l'élimination des toxines et le traitement des causes sous-jacentes."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications de la défaillance hépatique ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'encéphalopathie, l'hémorragie et l'infection."
}
},
{
"@type": "Question",
"name": "L'encéphalopathie hépatique est-elle grave ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des troubles neurologiques sévères et nécessite une attention médicale."
}
},
{
"@type": "Question",
"name": "Comment l'hémorragie se produit-elle ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hémorragie peut survenir en raison de la coagulation altérée et de la rupture de varices."
}
},
{
"@type": "Question",
"name": "Les infections sont-elles fréquentes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients peuvent développer des infections en raison d'une immunité affaiblie."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que le syndrome hépatopulmonaire ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "C'est une complication rare où le foie affecte la fonction pulmonaire, entraînant des difficultés respiratoires."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'alcoolisme, l'hépatite virale, l'obésité et l'exposition à des toxines."
}
},
{
"@type": "Question",
"name": "L'hépatite C augmente-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'hépatite C est un facteur de risque majeur pour le développement de la défaillance hépatique."
}
},
{
"@type": "Question",
"name": "Le diabète est-il un facteur de risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le diabète peut augmenter le risque de maladies hépatiques et de défaillance hépatique."
}
},
{
"@type": "Question",
"name": "L'obésité influence-t-elle la santé du foie ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'obésité est liée à la stéatose hépatique et à un risque accru de défaillance."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils être un risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent endommager le foie et augmenter le risque de défaillance."
}
}
]
}
]
}
Laparoscopic cholecystectomy (LC) with laparoscopic common bile duct exploration (LCBDE) is gaining traction for the management of choledocholithiasis. Liver function tests (LFTs) are often used to de...
Although several liver- and inflammation-based scores to predict the clinical course of patients with coronavirus disease 2019 (COVID-19) have been evaluated, no direct comparison regarding their pred...
1038 patients (608 males, age 63.5 ± 17 years) hospitalized with documented COVID-19 infection to the non-ICU ward, were included retrospectively. Clinical and laboratory characteristics on admission ...
One hundred and twenty-four patients (11.9%) died during hospitalization after 8 (3-72) days. In multivariate analysis, FIB-4 (hazard ratio, 1.11; 95% confidence interval (CI), 1.034-1.19; P = 0.004),...
FIB-4 was an independent factor for mortality with better performance compared to other liver function test- and inflammation-based scores in patients with COVID-19, while CAR was the only score indep...
The effect of induction chemotherapy on liver function in patients with acute lymphoblastic leukemia is not well documented in Ethiopia. This study assessed hepatotoxicity in patients with acute lymph...
This study investigated whether acute liver injury (ALI) persisted and identified predictors of ALI recovery [as indicated by alanine aminotransferase (ALT) level] at hospital discharge and 2 months p...
The aim of this study was to investigate the prognostic significance of PD-1 inhibitor therapy in nasopharyngeal carcinoma (NPC) and to develop a nomogram to estimate individual risks....
We retrospectively analyzed 162 NPC patients who were administered the PD-1 inhibitor combined with radiotherapy and chemotherapy at the Sun Yat-Sen University Cancer Center. In total, 108 NPC patient...
Univariate and multivariate analyses indicated that the metastasis stage, the levels of ALT, the AST/ALT ratio, and the LDH were independent risk factors associated with the prognosis of PD-1 inhibito...
Predicting PFS in NPC patients based on liver function-related indicators before PD-1 treatment may help clinicians predict the efficacy of PD-1 treatment in these patients....
To assess the predictive value of intraoperative indocyanine green (ICG) test in patients undergoing staged hepatectomy....
We analyzed intraoperative ICG measurements of future liver remnant (FLR), preoperative ICG, volumetry, and hepatobiliary scintigraphy in 15 patients undergoing associated liver partition and portal v...
Median intraoperative R15 (ICG retention rate at 15 min) correlated significantly with CCI® at discharge (p = 0.05) and with CCI® at 90 days (p = 0.0036). Preoperative ICG, volumetry, and scintigraphy...
This pilot study suggests that intraoperative ICG clearance determines the functional capacity of the future liver remnant more accurately than preoperative tests. This may further reduce the number o...
Patients with liver disease can be stratified for risk of liver-related ill health by degree of hepatic fibrosis. The Enhanced liver fibrosis (ELF) test was developed to quantify hepatic fibrosis non-...
Searches of PubMed and EMBASE were conducted between October 2020 and November 2021 to identify studies reporting the diagnostic accuracy of the ELF test compared to histology in liver disease patient...
Meta-analysis revealed considerable variability in the ability of ELF to stage fibrosis across disease aetiologies. Research has mostly focused on viral hepatitis and NAFLD. There is currently a lack ...
Clinical laboratory examinations frequently include biochemical analysis of the liver. The presence of alanine aminotransferase (ALT) and aspartate transaminase (AST) in serum can be used to identify ...
Pre-eclampsia can be described as new-onset hypertension (blood pressure ≥140/90 mmHg) together with proteinuria (24-hr urinary protein ≥ 0.3 g) or any indication of end-organ damage after 20 weeks of...
An institutional-based comparative cross-sectional study design was conducted, and a total of 102 subjects (51 patients with preeclampsia and 51 normotensive pregnant women) were recruited. The parame...
There were statistically significant differences in the mean serum uric acid, ALT, and AST levels between preeclamptic pregnant women and normotensive pregnant women (p<0.05). There were no statistica...
Our study revealed that serum uric acid, ALT, and AST levels were higher in pre-eclamptic pregnant women compared to those of normotensive pregnant women, and the differences were statistically signif...
To assess the largely undetermined separate and joint effects of sleep and liver function biomarkers on liver cancer....
Data of 356,894 participants without cancer at baseline in the UK Biobank were analyzed. Sleep score was evaluated using five sleep traits (sleep duration, chronotype, insomnia, snoring, and excessive...
After a median follow-up time of 13.1 years, 394 cases of incident liver cancer were documented. The multivariable-adjusted hazard ratio (HR) for liver cancer was 1.46 (95% confidence interval: 1.15-1...
Unhealthy sleep was associated with an increased risk of liver cancer, especially in participants with lower ALB levels or higher levels of ALT, AST, TBIL, GGT, ALP, or particularly TP....